Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Sickle cell patients share delight over approval of new treatment - Health officials have approved a £1.65 million treatment ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Today’s headlines highlight critical developments in genetic medicine, global politics, and the latest updates from the ...

The Women Health Belly Patch market is poised for substantial growth over the next decade, driven by increasing awareness of menstrual health ...

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

The global CAD dental software market is projected to reach a value of 3.2 billion USD by 2032, expanding at a 7.17% CAGR. Key market drivers include ...

The use of march-in rights to target pricy drugs has been a controversial issue across several administrations.

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.

A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...